https://doi.org/10.17037/DATA.00002321
Data collected as part of a cross-sectional study of Public Health Workers (PHWs) and Healthcare Workers (HCWs) perceptions of the implementation, practicality of, and barriers to implementation of COVID-19 non-pharmaceutical interventions (NPIs) and pharmaceutical interventions (PIs). It consists of two tabular datasets, one that contain survey responses collected from Public Health Workers, and a second that contains survey responses of Healthcare workers. Variables include data on socio-demographic characteristics and key COVID-19 NPIs and PIs. Each row represents one participant.
The Healthcare Workers Survey Dataset contains the following variables:
| Question Number | Question text | Answer code | Answer label |
| URN | Anonymised ID number | Integer | |
| Q1 | Are you a healthcare professional aged over 18 years and do you agree to take part in this survey? | ||
| 1 | Yes | ||
| 2 | No | ||
| Q2 | Are any population groups being shielded? | ||
| 1 | Yes | ||
| 2 | No | ||
| 3 | Don't know | ||
| Q2_a | Which population groups are being shielded? | ||
| 1 | Pregnant women | ||
| 2 | Older people | ||
| 3 | People who have long-term health conditions (e.g. HIV, diabetes, heart disease) | ||
| 4 | People who have weakened immune systems (e.g. tuberculosis (TB), cancer or transplant patients) | ||
| 5 | Don't know | ||
| 6 | Other | ||
| Q2_b | How easy do you think it is to implement shielding measures for pregnant women in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q2_b_i | Which of the following do you think are barriers to implementing shielding measures for pregnant women? | ||
| 1 | Lack of enforcement | ||
| 2 | Lack of policies and guidelines | ||
| 3 | Lack of communication between policy-makers and the public | ||
| 4 | Lack of communication between healthcare providers and the public | ||
| 5 | Lack of public support | ||
| 6 | Lack of home support for pregnant women (e.g. medical care, supply of food/medications) | ||
| 7 | Lack of financial support for pregnant women | ||
| 8 | Social stigma | ||
| 9 | Misinformation (e.g. rumours or myths) | ||
| 10 | Socio-cultural beliefs and practices | ||
| 11 | Other | ||
| 12 | Don't know | ||
| Q2_c | How easy do you think it is to implement shielding measures for older people in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q2_c_i | Which of the following do you think are barriers to implementing shielding measures for older people? | ||
| 1 | Lack of enforcement | ||
| 2 | Lack of policies and guidelines | ||
| 3 | Lack of communication between policy-makers and the public | ||
| 4 | Lack of communication between healthcare providers and the public | ||
| 5 | Lack of public support | ||
| 6 | Lack of home support for older people (e.g. medical care, supply of food/medications) | ||
| 7 | Social stigma | ||
| 8 | Misinformation (e.g. rumours or myths) | ||
| 9 | Socio-cultural beliefs and practices | ||
| 10 | Other | ||
| 11 | Don't know | ||
| Q2_d | How easy do you think it is to implement shielding measures for people with long-term conditions or those with weakened immune systems in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q2_d_i | Which of the following do you think are barriers to implementing shielding measures for people with long-term conditions or those with weakened immune systems? | ||
| 1 | Lack of enforcement | ||
| 2 | Lack of policies and guidelines | ||
| 3 | Lack of communication between policy-makers and the public | ||
| 4 | Lack of communication between policy-makers and healthcare providers | ||
| 5 | Lack of communication between healthcare providers and the public | ||
| 6 | Lack of public support | ||
| 7 | Lack of home support for people with long-term conditions or those with weakened immune systems (e.g. medical care, supply of food/medications) | ||
| 8 | Social stigma | ||
| 9 | Misinformation (e.g. rumours or myths) | ||
| 10 | Socio-cultural beliefs and practices | ||
| 11 | Other | ||
| 12 | Don't know | ||
| Q3 | Do you think a vaccine, if developed, should be introduced to prevent COVID-19? | ||
| 1 | Yes | ||
| 2 | No | ||
| 3 | Don't know | ||
| Q3_a | Do you think a vaccine should be prioritised for certain popualtion groups (e.g. pregnant women, healthcare workers, older people)? | ||
| 1 | Yes | ||
| 2 | No, everyone should be vaccinated | ||
| 3 | Don't know | ||
| Q3_a_i | Which of the following population groups do you think a vaccine should be prioritised for? (please select up to 3 groups) | ||
| 1 | Infants | ||
| 2 | School age children | ||
| 3 | Pregnant women | ||
| 4 | People who are working | ||
| 5 | People who are carers for dependents | ||
| 6 | Older people | ||
| 7 | People who have long-term health conditions (e.g. diabetes, heart disease) | ||
| 8 | People who have weakened immune systems (e.g. cancer or transplant patients) | ||
| 9 | People who are in closed settings (e.g. prisons, long-term care facilities) | ||
| 10 | People who are displaced (e.g. living in refugee camps) | ||
| 11 | Healthcare/ Social care/ Emergency professionals | ||
| 12 | Other | ||
| Q3_b | How easy do you think it is to provide a COVID-19 vaccine to these population groups in terms of practical challenges? | ||
| Q3_b_1 | Infants | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_2 | School age children | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_3 | Pregnant women | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_4 | People who are working | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_5 | People who are carers for dependents | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_6 | Older people | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_7 | People who have long-term health conditions (e.g. HIV, diabetes, heart disease) | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_8 | People who have weakened immune systems (e.g. tuberculosis, cancer or transplant patients) | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_9 | People who are in closed settings (e.g. prisons, long-term care facilities) | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_10 | People who are displaced (e.g. living in refugee camps) | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_11 | Healthcare/ Social care/ Emergency professionals | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_b_12 | People who are homeless | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q3_c | Which of the following do you think are barriers to implementing a COVID-19 vaccine? | ||
| 1 | Lack of vaccine supply | ||
| 2 | Lack of financial support | ||
| 3 | Lack of policies and guidelines | ||
| 4 | Lack of trained staff | ||
| 5 | Lack of communication between healthcare providers and the public | ||
| 6 | Lack of communication between policy-makers and the public | ||
| 7 | Lack of public support | ||
| 8 | Lack of equipment (e.g. cold chain) | ||
| 9 | Vaccine is manufactured in another country | ||
| 10 | Public fear of vaccine safety | ||
| 11 | Public fear of vaccine effectiveness | ||
| 12 | Socio-cultural beliefs and practices | ||
| 13 | Social stigma | ||
| 14 | Don't know | ||
| 15 | Other | ||
| Q4 | Are any medications (drugs) approved for COVID-19 use? | ||
| 1 | Yes | ||
| 2 | No | ||
| 3 | Don't know | ||
| 4 | Not applicable (NA) - I don't administer or prescribe medications in my profession | ||
| Q4_a | Which of the following medications/therapies have been approved to prevent/treat COVID-19 in your country? | ||
| 1 | Dexamethasone | ||
| 2 | Chloroquine | ||
| 3 | Hydroxychloroquine | ||
| 4 | Remdesivir | ||
| 5 | Favipiravir | ||
| 6 | Lopinavir-ritonavir (kaletra) | ||
| 7 | Interferon beta-1a | ||
| 8 | Convalescent plasma | ||
| 9 | Natural/traditional treatments | ||
| 10 | Other | ||
| 11 | Don't know | ||
| Q4_b | How easy do you think it is to provide a COVID-19 oral treatment in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q4_b_i | Which of the following do you think are barriers to providing a COVID-19 oral treatment? | ||
| 1 | Lack of policies and guidelines | ||
| 2 | Lack of communication between policy-makers and healthcare professionals | ||
| 3 | Lack of communication between healthcare providers and the public | ||
| 4 | Lack of communication between policy-makers and the public | ||
| 5 | Lack of public support | ||
| 6 | Misinformation (e.g. rumours or myths) | ||
| 7 | Socio-cultural beliefs and practices | ||
| 8 | Lack of medication supply | ||
| 9 | Lack of trained staff | ||
| 10 | Social stigma | ||
| 11 | Other | ||
| 12 | Don't know | ||
| Q4_c | How easy do you think it is to provide a COVID-19 treatment via an injection in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q4_c_i | Which of the following do you think are barriers to providing a COVID-19 treatment via an injection? | ||
| 1 | Lack of policies and guidelines | ||
| 2 | Lack of communication between policy-makers and healthcare professionals | ||
| 3 | Lack of communication between healthcare providers and the public | ||
| 4 | Lack of communication between policy-makers and the public | ||
| 5 | Lack of public support | ||
| 6 | Misinformation (e.g. rumours or myths) | ||
| 7 | Socio-cultural beliefs and practices | ||
| 8 | Lack of medication supply | ||
| 9 | Lack of equipment to administer treatment (e.g. syringes, needles) | ||
| 10 | Lack of trained staff | ||
| 11 | Social stigma | ||
| 12 | Other | ||
| 13 | Don't know | ||
| Q4_d | How easy do you think it is to provide a COVID-19 intravenous treatment in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q4_d_i | Which of the following do you think are barriers to providing a COVID-19 intravenous treatment? | ||
| 1 | Lack of policies and guidelines | ||
| 2 | Lack of communication between policy-makers and healthcare professionals | ||
| 3 | Lack of communication between healthcare providers and the public | ||
| 4 | Lack of communication between policy-makers and the public | ||
| 5 | Lack of public support | ||
| 6 | Misinformation (e.g. rumours or myths) | ||
| 7 | Socio-cultural beliefs and practices | ||
| 8 | Lack of medication supply | ||
| 9 | Lack of equipment to administer treatment (e.g. infusion pump) | ||
| 10 | Lack of trained staff | ||
| 11 | Social stigma | ||
| 12 | Other | ||
| 13 | Don't know | ||
| Q4_e | How easy do you think it is to provide a COVID-19 inhaled treatment (e.g. via nebuliser) in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q4_e_i | Which of the following do you think are barriers to providing a COVID-19 inhaled treatment? | ||
| 1 | Lack of policies and guidelines | ||
| 2 | Lack of communication between policy-makers and healthcare professionals | ||
| 3 | Lack of communication between healthcare providers and the public | ||
| 4 | Lack of communication between policy-makers and the public | ||
| 5 | Lack of public support | ||
| 6 | Misinformation (e.g. rumours or myths) | ||
| 7 | Socio-cultural beliefs and practices | ||
| 8 | Lack of medication supply | ||
| 9 | Lack of equipment to provide treatment (e.g. nebuliser machine) | ||
| 10 | Lack of trained staff | ||
| 11 | Social stigma | ||
| 12 | Other | ||
| 13 | Don't know | ||
| Q4_f | How easy do you think it is to provide blood products (e.g. transfusion of plasma) for COVID-19 treatment in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q4_f_i | Which of the following do you think are barriers to providing blood products (e.g. transfusion of plasma) for COVID-19 treatment? | ||
| 1 | Lack of policies and guidelines | ||
| 2 | Lack of communication between policy-makers and healthcare professionals | ||
| 3 | Lack of communication between healthcare providers and the public | ||
| 4 | Lack of communication between policy-makers and the public | ||
| 5 | Lack of public support | ||
| 6 | Misinformation (e.g. rumours or myths) | ||
| 7 | Socio-cultural beliefs and practices | ||
| 8 | Lack of donors | ||
| 9 | Lack of equipment to provide treatment (e.g. intravenous pump) | ||
| 10 | Lack of trained staff | ||
| 11 | Social stigma | ||
| 12 | Lack of blood services | ||
| 13 | Lack of technology infrastructure (e.g. laboratory, cold chain) | ||
| 14 | Other | ||
| 15 | Don't know | ||
| Q5 | Has the delivery of essential healthcare services been affected? | ||
| 1 | Yes | ||
| 2 | No | ||
| 3 | Don't know | ||
| Q5_a | Which of the following essential healthcare services have been affected? | ||
| 1 | Immunisation programmes | ||
| 2 | Maternal and Reproductive Health (e.g. facility-based deliveries, antenatal care) | ||
| 3 | HIV/AIDs | ||
| 4 | Tuberculosis | ||
| 5 | Malaria | ||
| 6 | Auxiliary services (e.g. laboratory and blood bank services, basic diagnostic imaging) | ||
| 7 | Critical inpatient therapies | ||
| 8 | Provision of medications and supplies for chronic or communicable diseases | ||
| 9 | Care for vulnerable populations | ||
| 10 | Emergency care that requires time-sensitive intervention | ||
| 11 | Other | ||
| Q5_b | How easy do you think it is for the following essential healthcare services to operate as normal in terms of practical challenges? | ||
| Q5_b_1 | Immunisation programmes | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_2 | Maternal and Reproductive Health (e.g. facility-based deliveries, antenatal care) | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_3 | HIV/AIDs | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_4 | Tuberculosis | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_5 | Malaria | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_6 | Auxiliary services (e.g. laboratory and blood bank services, basic diagnostic imaging) | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_7 | Critical inpatient therapies | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_8 | Provision of medications and supplies for chronic or communicable diseases | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_9 | Care for vulnerable populations | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_b_10 | Emergency care that requires time-sensitive intervention | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very Difficult | ||
| 5 | Don't know | ||
| 6 | Not applicable (NA) | ||
| Q5_c | Do you think there are barriers to providing essential healthcare services? | ||
| 1 | Yes | ||
| 2 | No | ||
| 3 | Don't know | ||
| Q5_c_i | Which of the following do you think are barriers to providing essential healthcare services? | ||
| 1 | Lack of trained staff | ||
| 2 | Lack of PPE | ||
| 3 | Lack of supply of treatments/vaccines | ||
| 4 | Lack of public support | ||
| 5 | Lack of communication with healthcare providers and the public | ||
| 6 | Lack of communication between policy-makers and healthcare professionals | ||
| 7 | Lack of policies and guidelines | ||
| 8 | Lack of communication with policy-makers and the public | ||
| 9 | Misinformation (e.g. rumours or myths) | ||
| 10 | Other | ||
| Q6 | Is PPE for COVID-19 being used to perform certain healthcare activities in your place of work? | ||
| 1 | Yes | ||
| 2 | No | ||
| 3 | Don't know | ||
| Q6_a | Which PPE for COVID-19 is being used for the following activities? | ||
| Q6_a_1 | Providing direct patient care or assistance to suspected COVID-19 patients | ||
| 1 | Medical masks | ||
| 2 | N-95/ FFP2/FFP3 masks | ||
| 3 | Gowns | ||
| 4 | Gloves | ||
| 5 | Aprons | ||
| 6 | Face shields | ||
| 7 | Goggles/ glasses | ||
| 8 | None | ||
| 9 | Don't know | ||
| 10 | Not applicable (NA) | ||
| Q6_a_2 | Providing direct patient care or assistance to confirmed COVID-19 patients | ||
| 1 | Medical masks | ||
| 2 | N-95/ FFP2/FFP3 masks | ||
| 3 | Gowns | ||
| 4 | Gloves | ||
| 5 | Aprons | ||
| 6 | Face shields | ||
| 7 | Goggles/ glasses | ||
| 8 | None | ||
| 9 | Don't know | ||
| 10 | Not applicable (NA) | ||
| Q6_a_3 | Providing direct care to COVID-19 patients in settings where aerosol-generating procedures are frequently performed (e.g. open suctioning, cardiopulmonary resuscitation) | ||
| 1 | Medical masks | ||
| 2 | N-95/ FFP2/FFP3 masks | ||
| 3 | Gowns | ||
| 4 | Gloves | ||
| 5 | Aprons | ||
| 6 | Face shields | ||
| 7 | Goggles/ glasses | ||
| 8 | None | ||
| 9 | Don't know | ||
| 10 | Not applicable (NA) | ||
| Q6_a_4 | Collecting laboratory samples | ||
| 1 | Medical masks | ||
| 2 | N-95/ FFP2/FFP3 masks | ||
| 3 | Gowns | ||
| 4 | Gloves | ||
| 5 | Aprons | ||
| 6 | Face shields | ||
| 7 | Goggles/ glasses | ||
| 8 | None | ||
| 9 | Don't know | ||
| 10 | Not applicable (NA) | ||
| Q6_a_5 | Interviewing and assessing persons with or without symptoms (no direct contact/physical distance of at least 1 metre) | ||
| 1 | Medical masks | ||
| 2 | N-95/ FFP2/FFP3 masks | ||
| 3 | Gowns | ||
| 4 | Gloves | ||
| 5 | Aprons | ||
| 6 | Face shields | ||
| 7 | Goggles/ glasses | ||
| 8 | None | ||
| 9 | Don't know | ||
| 10 | Not applicable (NA) | ||
| Q6_b | How easy do you think it is to implement PPE for COVID-19 to perform healthcare activities in terms of practical challenges? | ||
| 1 | Very easy | ||
| 2 | Easy | ||
| 3 | Difficult | ||
| 4 | Very difficult | ||
| 5 | Don't know | ||
| Q6_b_i | Which of the following do you think are barriers to implementing PPE for COVID-19 to perform healthcare activities? | ||
| 1 | Lack of N-95 / FFP2 / FFP3 masks | ||
| 2 | Lack of medical masks | ||
| 3 | Lack of eye protection equipment | ||
| 4 | Lack of gloves | ||
| 5 | Lack of gowns | ||
| 6 | Lack of policies and guidelines | ||
| 7 | Lack of communication between policy-makers and healthcare professionals | ||
| 8 | Lack of awareness of policies and guidelines among healthcare professionals | ||
| 9 | Insufficient staff training | ||
| 10 | Discomfort of wearing PPE | ||
| 11 | Poor quality of PPE | ||
| 12 | Misinformation (e.g. rumours or myths) | ||
| 13 | Socio-cultural beliefs and practices | ||
| 14 | Social stigma | ||
| 15 | Other | ||
| 16 | Don't know | ||
| Q7 | What is your profession? | ||
| 1 | Doctor | ||
| 2 | Nurse | ||
| 3 | Midwife | ||
| 4 | Community health worker | ||
| 5 | Other | ||
| Q8 | What type of health facility do you work at/with? | ||
| 1 | Community clinic/health post | ||
| 2 | Government local/district hospital | ||
| 3 | Government referral hospital | ||
| 4 | Private community clinic | ||
| 5 | Private local/district hospital | ||
| 6 | Private referral hospital | ||
| 7 | Research institute | ||
| 8 | Other | ||
| Q9 | Please tell us which country you have answered the survey questions for: | ||
| 1 | Afghanistan | ||
| 2 | Albania | ||
| 3 | Algeria | ||
| 4 | Andorra | ||
| 5 | Angola | ||
| 6 | Antigua and Barbuda | ||
| 7 | Argentina | ||
| 8 | Armenia | ||
| 9 | Australia | ||
| 10 | Austria | ||
| 11 | Azerbaijan | ||
| 12 | Bahamas | ||
| 13 | Bahrain | ||
| 14 | Bangladesh | ||
| 15 | Barbados | ||
| 16 | Belarus | ||
| 17 | Belgium | ||
| 18 | Belize | ||
| 19 | Benin | ||
| 20 | Bhutan | ||
| 21 | Bolivia | ||
| 22 | Bosnia and Herzegovina | ||
| 23 | Botswana | ||
| 24 | Brazil | ||
| 25 | Brunei Darussalam | ||
| 26 | Bulgaria | ||
| 27 | Burkina Faso | ||
| 28 | Burundi | ||
| 29 | Cabo Verde | ||
| 30 | Cambodia | ||
| 31 | Cameroon | ||
| 32 | Canada | ||
| 33 | Central African Republic | ||
| 34 | Chad | ||
| 35 | Chile | ||
| 36 | China | ||
| 37 | Colombia | ||
| 38 | Comoros | ||
| 39 | Congo | ||
| 40 | Costa Rica | ||
| 41 | Côte d'Ivoire | ||
| 42 | Croatia | ||
| 43 | Cuba | ||
| 44 | Cyprus | ||
| 45 | Czech Republic | ||
| 46 | Democratic People's Republic of Korea | ||
| 47 | Democratic Republic of the Congo | ||
| 48 | Denmark | ||
| 49 | Djibouti | ||
| 50 | Dominica | ||
| 51 | Dominican Republic | ||
| 52 | Ecuador | ||
| 53 | Egypt | ||
| 54 | El Salvador | ||
| 55 | Equatorial Guinea | ||
| 56 | Eritrea | ||
| 57 | Estonia | ||
| 58 | Eswatini | ||
| 59 | Ethiopia | ||
| 60 | Fiji | ||
| 61 | Finland | ||
| 62 | France | ||
| 63 | Gabon | ||
| 64 | Gambia (Republic of The) | ||
| 65 | Georgia | ||
| 66 | Germany | ||
| 67 | Ghana | ||
| 68 | Greece | ||
| 69 | Grenada | ||
| 70 | Guatemala | ||
| 71 | Guinea | ||
| 72 | Guinea Bissau | ||
| 73 | Guyana | ||
| 74 | Haiti | ||
| 75 | Honduras | ||
| 76 | Hungary | ||
| 77 | Iceland | ||
| 78 | India | ||
| 79 | Indonesia | ||
| 80 | Iran (Islamic Republic of) | ||
| 81 | Iraq | ||
| 82 | Ireland | ||
| 83 | Israel | ||
| 84 | Italy | ||
| 85 | Jamaica | ||
| 86 | Japan | ||
| 87 | Jordan | ||
| 88 | Kazakhstan | ||
| 89 | Kenya | ||
| 90 | Kiribati | ||
| 91 | Kuwait | ||
| 92 | Kyrgyzstan | ||
| 93 | Lao People's Democratic Republic | ||
| 94 | Latvia | ||
| 95 | Lebanon | ||
| 96 | Lesotho | ||
| 97 | Liberia | ||
| 98 | Libya | ||
| 99 | Liechtenstein | ||
| 100 | Lithuania | ||
| 101 | Luxembourg | ||
| 102 | Madagascar | ||
| 103 | Malawi | ||
| 104 | Malaysia | ||
| 105 | Maldives | ||
| 106 | Mali | ||
| 107 | Malta | ||
| 108 | Marshall Islands | ||
| 109 | Mauritania | ||
| 110 | Mauritius | ||
| 111 | Mexico | ||
| 112 | Micronesia (Federated States of) | ||
| 113 | Monaco | ||
| 114 | Mongolia | ||
| 115 | Montenegro | ||
| 116 | Morocco | ||
| 117 | Mozambique | ||
| 118 | Myanmar | ||
| 119 | Namibia | ||
| 120 | Nauru | ||
| 121 | Nepal | ||
| 122 | Netherlands | ||
| 123 | New Zealand | ||
| 124 | Nicaragua | ||
| 125 | Niger | ||
| 126 | Nigeria | ||
| 127 | North Macedonia | ||
| 128 | Norway | ||
| 129 | Oman | ||
| 130 | Palau | ||
| 131 | Panama | ||
| 132 | Papua New Guinea | ||
| 133 | Paraguay | ||
| 134 | Peru | ||
| 135 | Philippines | ||
| 136 | Poland | ||
| 137 | Portugal | ||
| 138 | Qatar | ||
| 139 | Republic of Korea | ||
| 140 | Republic of Moldova | ||
| 141 | Romania | ||
| 142 | Russian Federation | ||
| 143 | Rwanda | ||
| 144 | Saint Kitts and Nevis | ||
| 145 | Saint Lucia | ||
| 146 | Saint Vincent and the Grenadines | ||
| 147 | Samoa | ||
| 148 | San Marino | ||
| 149 | Sao Tome and Principe | ||
| 150 | Saudi Arabia | ||
| 151 | Senegal | ||
| 152 | Serbia | ||
| 153 | Seychelles | ||
| 154 | Sierra Leone | ||
| 155 | Singapore | ||
| 156 | Slovakia | ||
| 157 | Slovenia | ||
| 158 | Solomon Islands | ||
| 159 | Somalia | ||
| 160 | South Africa | ||
| 161 | South Sudan | ||
| 162 | Spain | ||
| 163 | Sri Lanka | ||
| 164 | Sudan | ||
| 165 | Suriname | ||
| 166 | Sweden | ||
| 167 | Switzerland | ||
| 168 | Syrian Arab Republic | ||
| 169 | Tajikistan | ||
| 170 | Thailand | ||
| 171 | Timor-Leste | ||
| 172 | Togo | ||
| 173 | Tonga | ||
| 174 | Trinidad and Tobago | ||
| 175 | Tunisia | ||
| 176 | Turkey | ||
| 177 | Turkmenistan | ||
| 178 | Tuvalu | ||
| 179 | Uganda | ||
| 180 | Ukraine | ||
| 181 | United Arab Emirates | ||
| 182 | United Kingdom of Great Britain and Northern Ireland | ||
| 183 | United Republic of Tanzania | ||
| 184 | United States of America | ||
| 185 | Uruguay | ||
| 186 | Uzbekistan | ||
| 187 | Vanuatu | ||
| 188 | Venezuela, Bolivarian Republic of | ||
| 189 | Vietnam | ||
| 190 | Yemen | ||
| 191 | Zambia | ||
| 192 | Zimbabwe | ||
| 193 | Other | ||
| Q10 | What is your age? | ||
| 1 | 18 - 35 | ||
| 2 | 35 - 44 | ||
| 3 | 45 - 54 | ||
| 4 | 55 - 64 | ||
| 5 | 65 - 74 | ||
| 6 | 75 and over | ||
| 7 | Prefer not to say | ||
| Q11 | What is your gender? | ||
| 1 | Male | ||
| 2 | Female | ||
| 3 | Transgender | ||
| 4 | Another gender | ||
| 5 | Prefer not to say |